title: Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data.
abstract: In this paper, we will briefly deal with the background for the possible effects of long-chain marine n-3 (also called omega-3) polyunsaturated fatty acids (PUFA) in coronary heart disease (CHD) and then focus on findings from clinical trials in humans. We will not deal with effects of alpha-linolenic acid, the non-marine type of n-3 PUFA derived from plant oils.
authors.affiliation: Department of Cardiology, Center for Cardiovascular Research, Aalborg Sygehus, Arhus University Hospitals, Denmark. ebs@dadlnet.dk
authors.forename: Erik Berg
authors.initials: EB
authors.lastname: Schmidt
authors.forename: Lars Hvilsted
authors.initials: LH
authors.lastname: Rasmussen
authors.forename: Jeppe Grøndahl
authors.initials: JG
authors.lastname: Rasmussen
authors.forename: Albert Marni
authors.initials: AM
authors.lastname: Joensen
authors.forename: Martin Bruun
authors.initials: MB
authors.lastname: Madsen
authors.forename: Jeppe Hagstrup
authors.initials: JH
authors.lastname: Christensen
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000178:diet therapy* / Q000517:prevention & control; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000097:blood; D005395:Fish Oils / Q000008:administration & dosage / Q000737:chemistry; D005399:Fishes; D006801:Humans; D012307:Risk Factors
chemical_list: D015525:Fatty Acids, Omega-3; D005395:Fish Oils